Telix Pharmaceuticals Limited Comprehensive Income
Telix Pharmaceuticals Limited (TLPPF) reported Comprehensive Income of -$14.12 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-20.
Financial Statements › Income Statement › Unrealized Gains
ifrs-full:ComprehensiveIncome · last filed 2026-02-20
AUD
| Period end | Comprehensive Income 12 month |
|---|---|
| 2024-12-31 | 92.62M AUD 20-F · filed 2025-02-24 |
| 2023-12-31 | -536.00K AUD 20-F · filed 2025-02-24 |
| 2022-12-31 | -103.49M AUD 20-F · filed 2025-02-24 |
USD
| Period end | Comprehensive Income 12 month |
|---|---|
| 2025-12-31 | -$14.12M 20-F · filed 2026-02-20 |
| 2024-12-31 | $35.97M 20-F · filed 2026-02-20 |
| 2023-12-31 | $1.73M 20-F · filed 2026-02-20 |